Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR-5.3%
5Y CAGR+21.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-5.3%/yr
vs +182.9%/yr prior
5Y CAGR
+21.8%/yr
Recent deceleration
Acceleration
-188.2pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.00M | +18.4% |
| 2024 | $17.74M | -5.7% |
| 2023 | $18.82M | -23.8% |
| 2022 | $24.71M | +21.2% |
| 2021 | $20.39M | +160.6% |
| 2020 | $7.82M | +1841.4% |
| 2019 | $403000.00 | +4.4% |
| 2018 | $386000.00 | - |